Trials / Conditions / Stage II Gastric Cancer

Stage II Gastric Cancer

3 registered clinical trials studyying Stage II Gastric Cancer.

Status	Trial	Sponsor	Phase
Completed	Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydroch NCT01561014	Wake Forest University Health Sciences	Phase 1
Terminated	EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer NCT00087191	National Cancer Institute (NCI)	N/A
Completed	Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the St NCT00062374	National Cancer Institute (NCI)	Phase 2